Contact this trialFirst, we need to learn more about you.
Cancer Vaccine
Adagloxad Simolenin + OBI-821 for Triple Negative Breast Cancer
Recruiting2 awardsPhase 3
Lincoln, Nebraska
This trial is testing a new treatment that combines two substances to help the immune system fight a specific type of high-risk breast cancer. It focuses on patients whose cancer does not respond well to usual treatments.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service